<DOC>
	<DOCNO>NCT02239991</DOCNO>
	<brief_summary>A point-of-care bleeding management protocol base global viscoelastic test ( thromboelastometry ) change amount blood product use orthotopic liver transplant .</brief_summary>
	<brief_title>Management Perioperative Coagulopathy With Thromboelastometry ( ROTEM ) Liver Transplant</brief_title>
	<detailed_description>Patients liver disease frequently acquire complex disorder hemostasis secondary disease . The fundamental key management coagulopathy cirrhotic patient knowledge hepatic dysfunction result impairment pro-hemostatic factor anti-hemostatic factor disproportionate manner lead clinical picture bleed thrombosis . Routine test coagulation prothrombin time ( PT , INR ) activate partial thromboplastin time ( APTT ) although prolong cirrhotic patient predict bleed . Global viscoelastic test whole blood ( TEG / ROTEM ) produce dynamic composite image entire coagulation process potential provide clinically relevant information patient liver disease allow rational use blood product liver transplantation .</detailed_description>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>patient national list liver transplant assign transplant Hospital Israelita Albert Einstein give free clarified consent term . acute liver failure age 18 combine transplant transplantation le 30 day incomplete medical record , 20 % miss data .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Point care</keyword>
	<keyword>perioperative hemostasis</keyword>
	<keyword>thromboelastometry</keyword>
	<keyword>bleeding risk</keyword>
	<keyword>end-stage liver disease</keyword>
	<keyword>hepatic coagulopathy</keyword>
	<keyword>whole blood coagulation</keyword>
</DOC>